AVA-3001

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameAVA-3001

Drug Alias NameNKT cell-based vaccine (Avalia Immunotherapies)AVA-1075AVA-3001

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapyVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunomodulatorsNatural killer cells modulators

TargetsNot applicable

Therapy Area/IndicationsHypersensitivity

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNew Zealand

CombinationsYes

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAvalia Immunotherapies Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAvalia Immunotherapies Ltd

Active IndicationsN/A

Inactive IndicationsHypersensitivity

Other Information

ATC CodeN/A